Utilities and power generation companies are bolstering operational efficiency and plant reliability by implementing advanced ...
Results from the Phase 3 VELA clinical trials at Week 52 in adults with moderate-to-severe hidradenitis suppurativa (HS) demonstrate sonelokimab’s (SLK) potential best-in-class and best-in-disease ...
This agreement represents NetraMark's ninth commercial contract since the start of its current fiscal year and demonstrates growing interest in AI-enabled clinical trial analytics, like NetraAI, among ...
Not enough children in Milwaukee are being screened for lead. Kids with lead poisoning are slipping through the cracks.
This agreement represents NetraMark's ninth commercial contract since the start of its current fiscal year and demonstrates growing interest in AI-enabled clinical trial analytics, like NetraAI, among ...
CNX Resources is a disciplined capital allocator, prioritizing FCF per share and aggressive buybacks over production growth. Read more on CNX stock here.
The Nuclear Regulatory Commission (NRC) has proposed what may be its most consequential reactor-licensing overhaul in a ...
Many of the insights hitting soccer pitches today trace back to Jesse Davis and a team of computer scientists open-sourcing tools for some of the sport’s trickiest problems.
Doug Wintemute is a staff writer for Forbes Advisor. After completing his master’s in English at York University, he began his writing career in the higher education space. Over the past decade, Doug ...
Viberate reports July 2026 music festivals ranked by lineup value, highlighting how lineup strength and ticket price impact ...
Vistagen (Nasdaq: VTGN), a late clinical-stage biopharmaceutical company pioneering neuroscience with nose-to-brain neurocircuitry to develop and commercialize a new class of intranasal product ...
TOMAGOLD CORPORATION (TSXV: LOT; OTCPK: TOGOF) (“ TomaGold ” or the “ Company ”) is pleased to announce assay results from the first of five extension holes, TOM-25-011EXT, completed as part of Phase ...